Literature DB >> 16189627

Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease.

Atsushi Enomoto1, Hitoshi Endou.   

Abstract

Renal proximal and distal tubules are highly polarized epithelial cells that carry out the specialized directional transport of various solutes. This renal function, which is essential for homeostasis in the body, is achieved through the close pairing of apical and basolateral carriers expressed in the renal epithelial cells. The family of organic anion transporters (OATs), which belong to the major facilitator superfamily (SLC22A), are expressed in the renal epithelial cells to regulate the excretion and reabsorption of endogenous and exogenous organic anions. We now understand that these OATs are crucial components in the renal handling of drugs and their metabolites, and they are implicated in various clinically important drug interactions, and their adverse reactions. In recent years, the molecular entities of these transporters have been identified, and their function and regulatory mechanisms have been partially clarified. Workers in this field have identified URAT1 (urate transporter 1), a novel member of the OAT family that displays unique and selective substrate specificity compared with other multispecific OATs. In the OAT family, URAT1 is the main transporster responsible for human genetic diseases. In this review, we introduce and discuss some novel aspects of OATs, with special emphasis on URAT1, in the context of their biological significance, functional regulation, and roles in human disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189627     DOI: 10.1007/s10157-005-0368-5

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  73 in total

1.  Modulation of the basolateral and apical step of transepithelial organic anion secretion in proximal tubular opossum kidney cells. Acute effects of epidermal growth factor and mitogen-activated protein kinase.

Authors:  C Sauvant; H Holzinger; M Gekle
Journal:  J Biol Chem       Date:  2001-02-02       Impact factor: 5.157

2.  Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains.

Authors:  O Kocher; N Comella; K Tognazzi; L F Brown
Journal:  Lab Invest       Date:  1998-01       Impact factor: 5.662

3.  Patients with renal hypouricemia with exercise-induced acute renal failure and chronic renal dysfunction.

Authors:  Y Kikuchi; H Koga; Y Yasutomo; Y Kawabata; E Shimizu; M Naruse; S Kiyama; H Nonoguchi; K Tomita; Y Sasatomi; S Takebayashi
Journal:  Clin Nephrol       Date:  2000-06       Impact factor: 0.975

4.  Recurrence of acute renal failure and renal hypouricaemia.

Authors:  T Murakami; H Kawakami; M Fukuda; H Shiigi
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

5.  Two male siblings with hereditary renal hypouricemia and exercise-induced ARF.

Authors:  Motoko Tanaka; Kazuko Itoh; Kazunori Matsushita; Kazutaka Matsushita; Naoki Wakita; Masataka Adachi; Hiroshi Nonoguchi; Kenichiro Kitamura; Makoto Hosoyamada; Hitoshi Endou; Kimio Tomita
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

6.  Characterization of uremic toxin transport by organic anion transporters in the kidney.

Authors:  Tsuneo Deguchi; Hiroyuki Kusuhara; Akira Takadate; Hitoshi Endou; Masaki Otagiri; Yuichi Sugiyama
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

7.  Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux.

Authors:  Adiya Bakhiya; Andrew Bahn; Gerhard Burckhardt; Natascha Wolff
Journal:  Cell Physiol Biochem       Date:  2003

8.  Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules.

Authors:  Sophapun Ekaratanawong; Naohiko Anzai; Promsuk Jutabha; Hiroki Miyazaki; Rie Noshiro; Michio Takeda; Yoshikatsu Kanai; Samaisukh Sophasan; Hitoshi Endou
Journal:  J Pharmacol Sci       Date:  2004-03       Impact factor: 3.337

Review 9.  Uric acid nephrolithiasis.

Authors:  A Halabe; O Sperling
Journal:  Miner Electrolyte Metab       Date:  1994

10.  Renal hypouricemia due to an isolated renal defect of urate transport.

Authors:  I Hisatome; K Ogino; M Saito; J Miyamoto; J Hasegawa; H Kotake; H Mashiba; S Nakamoto
Journal:  Nephron       Date:  1988       Impact factor: 2.847

View more
  47 in total

1.  Gout, diuretics and the kidney.

Authors:  E Pascual; M Perdiguero
Journal:  Ann Rheum Dis       Date:  2006-08       Impact factor: 19.103

Review 2.  Physiology, structure, and regulation of the cloned organic anion transporters.

Authors:  C Srimaroeng; J L Perry; J B Pritchard
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

3.  Uric acid: a modulator of prostate cells and activin sensitivity.

Authors:  Febbie Sangkop; Geeta Singh; Ely Rodrigues; Elspeth Gold; Andrew Bahn
Journal:  Mol Cell Biochem       Date:  2016-02-24       Impact factor: 3.396

Review 4.  Pharmacology behind Common Drug Nephrotoxicities.

Authors:  Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-05       Impact factor: 8.237

Review 5.  ABCG transporters and disease.

Authors:  Owen M Woodward; Anna Köttgen; Michael Köttgen
Journal:  FEBS J       Date:  2011-06-13       Impact factor: 5.542

6.  A case of renal hypouricemia and a G774A gene mutation causing acute renal injury that was improved by hemodialysis.

Authors:  Shuma Hirashio; Kyoko Yamada; Takayuki Naito; Takao Masaki
Journal:  CEN Case Rep       Date:  2012-03-30

Review 7.  Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease.

Authors:  Li Wang; Douglas H Sweet
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

Review 8.  Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.

Authors:  Naohiko Anzai; Promsuk Jutabha; Sirirat Amonpatumrat-Takahashi; Hiroyuki Sakurai
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

9.  [Molecular basis of primary renal hyperuricemia : role of the human urate transporter hURAT1].

Authors:  S Unger; A-K Tausche; S Kopprasch; S R Bornstein; M Aringer; J Grässler
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

Review 10.  [New knowledge on the pathophysiology and therapy of gout].

Authors:  A So
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.